Physician profile
Sanaz Hariri
NPI 1134255888
$881.50
in general payments reported to CMS, 2019-2025
17 companies · $60.10 in 2025
The $60.10 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $535 · 2020: $22.37 · 2021: $163 · 2022: $54.84 · 2023: $45.60 · 2025: $60.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $105.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $142.85 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $124.59 | 2019 | |
| Heron Therapeutics, INC. | $121.84 | 2021 | |
| Smith+Nephew, INC. | $120.82 | 2019 | |
| Medtronic USA, INC. | $98.75 | 2019 | |
| Avanos Medical | $41.61 | 2025 | On-Q Pump and Accessories |
| Acelrx Pharmaceuticals, INC. | $37.75 | 2019-2021 | |
| Ethicon US, LLC | $34.60 | 2021-2022 | |
| Ermi LLC | $22.37 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $21.74 | 2022 | |
| Trevena, INC. | $18.84 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $18.49 | 2025 | |
| Spr Therapeutics, INC | $17.25 | 2023 | Sprint Pns System |
| Stryker Corporation | $16.37 | 2019 | |
| Kci USA, INC. | $15.28 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evolution Surgical, INC | $15.27 | 2023 | |
| Depuy Synthes Sales INC. | $13.08 | 2023 | Orthovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanaz Hariri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.